End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
283,500 KRW | -1.05% | -4.87% | -19.57% |
May. 16 | Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Neutral |
Resistance | 310,000.00 | 327,000.00 | 355,000.00 |
Spread/Res. | -8.55% | -13.30% | -20.14% |
Spread/Supp. | -0.29% | +3.83% | +5.92% |
Support | 284,314.00 | 273,039.00 | 267,647.00 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- A128940 Stock
- Charts Hanmi Pharm. Co., Ltd.